Anti-arrhythmic Drugs


Sodium-channel blockers are in Class I.

Beta-blockers are in Class II.

Potassium-channel blockers, Class III.

Calcium-channel blockers are in class IV.

Adenosine is a kind of adenosine. - a supplement of electrolytes (magnesium and potassium salts) - digitalis derivatives (cardiac glycosides) Amiodarone is the most powerful antiarrhythmic drug available. Amiodarone's adverse event profile can be severe, with gastrointestinal side effects being the most common. Dronedarone was the antiarrhythmic medicine with the best tolerability, with the fewest severe adverse effects and a significant reduction in the risk of stroke. In patients without structural heart disease, we use propafenone, flecainide, sotalol, and dronedarone as first-line therapies. Beta-blockers affect predominantly slow-channel tissues (Sino atrial [SA] and atrioventricular [AV] nodes), where they reduce rate of automaticity, slow conduction velocity, and prolong refractoriness. Blood pressure medications known as alpha blockers are a type of blood pressure medication. They work by stopping the hormone norepinephrine from tightening the muscles in the walls of smaller arteries and veins, lowering blood pressure. The blood vessels remain open and relaxed as a result. Blood flow is improved, and blood pressure is reduced as a result.



 


    Related Conference of Anti-arrhythmic Drugs

    May 30-31, 2024

    6th Euro Cardiology Congress

    Vienna, Austria
    May 30-31, 2024

    39th World Congress on Heart Diseases

    Vienna, Austria
    June 20-21, 2024

    5th European Summit on Cardiology Research

    Dublin, Ireland
    July 16-17, 2024

    13th World Heart Congress

    Paris, France
    August 01-02, 2024

    38th World Congress on Heart Diseases

    Montreal, Canada
    September 16-17, 2024

    3rd Global Summit on Cardiology and Cardiac Surgery

    Paris, France
    October 24-25, 2024

    11th International Conference on Interventional Cardiology

    Zurich, Switzerland
    October 30-31, 2024

    7th Global Cardiovascular Research and Clinical Cardiology

    Vancouver, Canada

    Anti-arrhythmic Drugs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in